Zobrazeno 1 - 10 of 645 pro vyhledávání: '"B. Good"'
1
Akademický článek
Disease-Modifying Medications in Patients with Rheumatoid Arthritis in the USA: Trends from 2016 to 2021
Autor: Samuel K. Peasah, Elizabeth C. S. Swart, Yan Huang, Sandra L. Kane-Gill, Amy L. Seybert, Urvashi Patel, Chronis Manolis, Chester B. Good
Publikováno v: Drugs - Real World Outcomes, Vol 11, Iss 2, Pp 241-249 (2024)
Abstract Background Disease-modifying anti-rheumatic drugs (DMARDs), since their introduction in 1990, have revolutionized the management of rheumatoid arthritis. Newer DMARDs have recently been approved, influencing treatment patterns and clinical g
Externí odkaz: https://doaj.org/article/36c34275f52a496c8519d6bdc4ecb46b
Zobrazit plný text záznamu
2
Akademický článek
Maintenance of pig brain function under extracorporeal pulsatile circulatory control (EPCC)
Autor: Muhammed Shariff, Aksharkumar Dobariya, Obada Albaghdadi, Jacob Awkal, Hadi Moussa, Gabriel Reyes, Mansur Syed, Robert Hart, Cameron Longfellow, Debra Douglass, Tarek Y. El Ahmadieh, Levi B. Good, Vikram Jakkamsetti, Gauri Kathote, Gus Angulo, Qian Ma, Ronnie Brown, Misha Dunbar, John M. Shelton, Bret M. Evers, Sourav Patnaik, Ulrike Hoffmann, Amy E. Hackmann, Bruce Mickey, Matthias Peltz, Michael E. Jessen, Juan M. Pascual
Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Abstract Selective vascular access to the brain is desirable in metabolic tracer, pharmacological and other studies aimed to characterize neural properties in isolation from somatic influences from chest, abdomen or limbs. However, current methods fo
Externí odkaz: https://doaj.org/article/f27c134eed2846f4b5ca3dffb16c1331
Zobrazit plný text záznamu
3
Akademický článek
Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
Autor: Samuel K. Peasah, Yan Huang, John Venditto, Robert Brekosky, Daniel Belletti, Vanessa Campbell, Chronis Manolis, Chester B. Good
Publikováno v: Exploratory Research in Clinical and Social Pharmacy, Vol 12, Iss , Pp 100347- (2023)
Background: Outcomes-based agreements (OBA) are performance-based risk-sharing agreements between manufacturers and payers which provide the opportunity for collection and evaluation of real-world outcomes to supplement clinical trials. Objectives: T
Externí odkaz: https://doaj.org/article/0b069402493542f780727b113d920eed
Zobrazit plný text záznamu
5
Akademický článek
Isolation of the murine Glut1 deficient thalamocortical circuit: wavelet characterization and reverse glucose dependence of low and gamma frequency oscillations
Autor: Elysandra M. Solis, Levi B. Good, Rafael Granja Vázquez, Sourav Patnaik, Ana G. Hernandez-Reynoso, Qian Ma, Gustavo Angulo, Aksharkumar Dobariya, Stuart F. Cogan, Joseph J. Pancrazio, Juan M. Pascual, Vikram Jakkamsetti
Publikováno v: Frontiers in Neuroscience, Vol 17 (2023)
Glucose represents the principal brain energy source. Thus, not unexpectedly, genetic glucose transporter 1 (Glut1) deficiency (G1D) manifests with encephalopathy. G1D seizures, which constitute a prominent disease manifestation, often prove refracto
Externí odkaz: https://doaj.org/article/86266aa5aa284d798db3c4b1c8e80b58
Zobrazit plný text záznamu
6
Akademický článek
Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
Autor: Christopher LaFratte, Samuel K. Peasah, Yan Huang, Deanne Hall, Urvashi Patel, Chester B. Good
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 18 (2023)
Background PCSK9is (proprotein convertase subtilisin/kexin type 9 inhibitors) are well tolerated, potently lower cholesterol, and decrease cardiovascular events when added to statins. However, statin adherence may decrease after PCSK9i initiation and
Externí odkaz: https://doaj.org/article/4d1ba4fc2df744e490d97078dbdb3e57
Zobrazit plný text záznamu
7
Akademický článek
Trends in utilization and costs of migraine medications, 2017–2020
Autor: Jennifer L. Nguyen, Kiraat Munshi, Samuel K. Peasah, Elizabeth C. S. Swart, Monal Kohli, Rochelle Henderson, Chester B. Good
Publikováno v: The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Objective This study examines changes in utilization and costs trends associated with migraine medications. Background Migraine attacks are a burden to many patients. There are many pharmacotherapy options available with newer migraine drug
Externí odkaz: https://doaj.org/article/87713e6cdce944219602ac8a7fa73067
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje